Jeffrey Meckler

Jeffrey A. Meckler currently works at Children of Bellevue, Inc., as Director from 2001 and Travere Therapeutics, Inc., as Independent Director from 2016.
Mr. Meckler also formerly worked at Cypress Bioscience, Inc., as Chief Executive Officer & Director from 2011 to 2012, Cocrystal Pharma, Inc., as Chief Executive Officer & Director from 2015 to 2016, Trieber Therapeutics, Inc., as Chief Executive Officer in 2017, Indaptus Therapeutics, Inc., as Chief Executive Officer & Director from 2021 to 2025, Intec Parent, Inc. (United States), as President, CEO, Secretary & Director, Intec Pharma Ltd., as Vice Chairman & Chief Executive Officer from 2017 to 2021, QLT, Inc., as Independent Director from 2014 to 2016, Alveolus, Inc., as Director from 2007 to 2009, Andra Group, Inc., as Managing Director, Kyalin Biosciences, Inc., as Director from 2011 to 2012, and Clearfarma USA, as Director from 2010 to 2012.
Mr. Meckler received his graduate degree from Fordham University School of Law and undergraduate degree and graduate degree from Tepper School of Business.